Valuation: QuidelOrtho Corporation

Market Cap 981M 847M 796M 724M 1.36B 93.77B 1.38B 9.33B 3.65B 46.96B 3.68B 3.6B 156B P/E 2026 *
-3.47x
P/E 2027 * -5.14x
Enterprise Value 3.54B 3.06B 2.87B 2.61B 4.91B 338B 4.99B 33.65B 13.16B 169B 13.29B 13B 563B EV / Sales 2026 *
1.39x
EV / Sales 2027 * 1.34x
Free-Float
99.11%
Yield 2026 *
-
Yield 2027 * -
1 day-5.24%
1 week+16.40%
Current month-14.73%
1 month-21.56%
3 months+38.57%
6 months-39.36%
Current year-49.93%
1 week 12.07
Extreme 12.0657
15.52
1 month 11.41
Extreme 11.41
18.19
Current year 9.92
Extreme 9.92
35.58
1 year 9.92
Extreme 9.92
35.58
3 years 9.92
Extreme 9.92
84.6
5 years 9.92
Extreme 9.92
180.06
10 years 9.92
Extreme 9.92
306.72
Manager TitleAgeSince
Chief Executive Officer 61 06/05/2024
Director of Finance/CFO 48 06/07/2026
Chief Operating Officer 57 15/11/2024
Director TitleAgeSince
Chairman 72 11/12/2022
Director/Board Member 71 01/01/2022
Director/Board Member 82 01/01/1993
Date Insider Type Main position Quantity % Market Cap.
15/07/26 Free

Chief Financial Officer

356,555 0.5251%
06/07/26 Other

Chief Financial Officer

0 0%
01/07/26 Fiscal year

EVP Global Port. Mgmt & Mkting

13,690 0.0202%
Change 5-day change 1-year change 3-year change Capi.($)
-5.24%+16.40%-44.85%-80.86% 981M
+1.02%+2.28%+20.16%-35.79% 17.1B
-2.98%+0.45%-10.29%+95.57% 1.76B
-0.44%-2.23%-26.22%+25.14% 985M
-0.05%+48.99%+70.10%-11.23% 779M
+0.95%+2.45%-36.26%-49.55% 696M
+3.92%+17.79%-35.32%-39.77% 646M
+5.89%+6.05%-40.58%-36.99% 443M
-0.99%+12.73%+50.98%+41.78% 414M
+0.26%+0.26%-3.17%-21.88% 383M
Average +0.23%+9.43%-5.54%-11.36% 2.42B
Weighted average by Cap. +0.50%+4.20%+10.97%-23.76%

Financials

2026 *2027 *
Net sales 2.55B 2.2B 2.07B 1.88B 3.53B 243B 3.59B 24.21B 9.47B 122B 9.56B 9.35B 405B 2.59B 2.24B 2.1B 1.91B 3.6B 248B 3.66B 24.64B 9.64B 124B 9.73B 9.52B 412B
Net income -269M -232M -218M -199M -373M -25.73B -380M -2.56B -1B -12.88B -1.01B -988M -42.81B -164M -142M -133M -121M -227M -15.67B -231M -1.56B -610M -7.85B -615M -602M -26.08B
Net Debt 2.56B 2.21B 2.08B 1.89B 3.55B 245B 3.61B 24.33B 9.51B 123B 9.61B 9.4B 407B 2.49B 2.15B 2.02B 1.84B 3.46B 238B 3.51B 23.69B 9.26B 119B 9.35B 9.15B 396B
Logo QuidelOrtho Corporation
QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Optix and others.
Employees
6,500
Date Price Change Volume
14/08/26 $14.30 -5.24% 917,947
13/08/26 $15.09 +1.75% 1,446,395
12/08/26 $14.83 +6.00% 1,953,334
11/08/26 $13.99 +1.75% 1,495,558
10/08/26 $13.75 +11.93% 2,808,677
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
14.30USD
Average target price
14.67USD
Spread / Average Target
+2.56%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. QDEL Stock